Leukapheresis Products Market Size, Share Analysis, Key Companies,...

Leukapheresis Products Market Size, Share Analysis, Key Companies, and Forecast To 2030

228

Posted 2022-09-09 05:15:38

Leukapheresis procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.

Currently, many companies are operating in the global leukapheresis products market. The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6767

The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical research are anticipated to propel the growth of the market over the forecast period. According to the National Institutes of Health (NIH) estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the period from 2006-2015. It also stated that the number of new cases may reach 60,300 in the year 2018. Despite the drivers, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hamper the market growth over the assessment period.

Key Players:

Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region. Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East & Africa has the least share of the global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region.

Segmentation:

The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.

The market, by application, has been segmented into research applications and therapeutic applications.

On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/leukapheresis-products-market-6767

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

Apoptosis Assays Market

The global apoptosis assays market held a market value of USD 2.99 billion in 2017 and is expected to register a CAGR of 9.4% during the forecast period.

Increasing R&D expenses and growing cell-based research are expected to drive the growth of the market. On the other hand, required high investment for research activities can restrain the market growth over the assessment period. Recently, in 2016, the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute received USD 5.1 million from the California Institute for Regenerative Medicine. This funding helps for the development of novel therapy for blinding retinal conditions. Furthermore, the National Institutes of Health (NIH) invested USD 1.65 billion for stem cell research in 2017. This funding drives the growth of the apoptosis assays market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6799

Regional Analysis:

Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and increasing funding for cell apoptosis assay. Europe is expected to hold the second largest position in the global market. Asia-Pacific is expected to be the fastest growing market. Furthermore, the Middle Eastern and African region is expected to account for the least market share in the global market.

Segmentation:

The global apoptosis assays market has been segmented into product, detection technology, application, and end user.

Based on product, the market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share and fastest growing segment of the global apoptosis assays market in 2017.

Based on detection technology, the market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others. The flow cytometry segment accounted for the largest share segment of the global apoptosis assays market in 2017.

Based on application, the market has been segmented into drug discovery and development, stem cell research, and others. The drug discovery and development segment accounted for the largest share of the global apoptosis assays market in 2017. The stem cell research was the fastest growing segment of the global apoptosis assays market in 2017.

Based on end user, the market has been segmented into pharmaceutical and biological companies, research institutes, and others. The pharmaceutical and biological companies segment accounted for the largest share of the global apoptosis assays market in 2017. Research institutes were the fastest growing segment of the global apoptosis assays market in 2017.